Company Search:
Advanced Search
Sponsored Links
Tus Pharmaceutical Group Co Ltd Company Snapshot
Tus Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tus Pharmaceutical Group Co Ltd with three other companies in this sector in CHINA : Shenzhen Chipscreen Biosciences Co Ltd (2020 sales of 269.47 million Chinese Renmimbi [US$41.46 million] of which 100% was Chidamide), Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (254.90 million Chinese Renmimbi [US$39.22 million] of which 76% was Pharmaceutical manufacturing), and Hainan Shuangcheng Pharmaceuticals Co Ltd (267.77 million Chinese Renmimbi [US$41.20 million] ).

Sales Analysis. Tus Pharmaceutical Group Co Ltd reported sales of 275.09 million Chinese Renmimbi (US$42.32 million) for the year ending December of 2020. This represents a decrease of 12.7% versus 2019, when the company's sales were 315.03 million Chinese Renmimbi. The sales level in 2020 was fairly close to the level five years ago: in 2015, Tus Pharmaceutical Group Co Ltd had sales of 294.72 million Chinese Renmimbi. Contributing to the drop in overall sales was the 20.9% decline in Western Medicine Manufacturing, from 25.63 million Chinese Renmimbi to 20.26 million Chinese Renmimbi. There were also decreases in sales in Chinese Medicine Healthcare Production (down 12.1% to 253.46 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Other Business (up 12.7% to 1.37 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tus Pharmaceutical Group Co Ltd
  Stock Performance Chart for Tus Pharmaceutical Group Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/16/2021): 8.15
(Figures in Chinese Renmimbi)
1 Week 3.8%   13 Weeks 3.0%  
4 Weeks 1.6%   52 Weeks -23.2%  
Tus Pharmaceutical Group Co Ltd Key Data:
  Ticker: 000590 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 275,090,121
(Year Ending Jan 2021).
Employees: 1,256
  Currency: Chinese Renmimbi Market Cap: 1,951,690,826
  Fiscal Yr Ends: December Shares Outstanding: 239,471,267
  Share Type: A Gu Closely Held Shares: 122,705,753
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.